The global cardiovascular devices market size was worth over USD 69.06 billion in 2025 and is poised to grow at a CAGR of around 7.8%, reaching USD 146.36 billion revenue by 2035, driven by growing minimal invasive medical procedures.

The India Cardiovascular Devices Market Report is Segmented by Product Type (Diagnostic & Monitoring Devices, Therapeutic & Surgical Devices), Application (Coronary Artery Disease, Arrhythmia & Conduction Disorders, Heart Failure & Cardiomyopathy, and More), End User (Hospitals & Cardiac Centres, Ambulatory Surgical Centres, and More). The Market Forecasts are Provided in Terms of Value (USD).

The United States Cardiovascular Devices Market Report is Segmented by Device Type (Diagnostic & Monitoring Devices [ECG Systems, Remote Cardiac Monitor, and More], Therapeutic & Surgical Devices [Coronary Stents, Catheters, Cardiac Rhythm Management, Heart Valves, Ventricular Assist Devices, and More]), Indication (Coronary Artery Disease, Arrhythmia, and More). The Market Forecasts are Provided in Terms of Value (USD).

The global cardiovascular devices market size reached USD 62.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 101.3 Billion by 2033, exhibiting a growth rate (CAGR) of 5.5% during 2025-2033. The introduction of interventional cardiology procedures, coupled with favorable reimbursement policies, are stimulating the market growth

IMARC Group provides an analysis of the key trends in each segment of the market, along with the cardiovascular devices market forecast at the global, regional, and country levels for 2025-2033. Our report has categorized the market based on the device type, application, and end user.

Cardiovascular Devices Market size was valued at USD 63.49 Billion in 2024 and is projected to reach USD 104.08 Billion by 2031, growing at a CAGR of 7.03% during the forecast period 2024-2031.

The market for cardiovascular devices is expanding significantly due to a number of important factors. First, the market is expanding due to the increased prevalence of cardiovascular illnesses (CVDs), such as heart failure, hypertension, and coronary artery disease. Cardiovascular devices, which include therapeutic tools like pacemakers, defibrillators, and stents as well as diagnostic instruments like electrocardiographs (ECGs) and imaging systems, are essential to the diagnosis, treatment, and management of cardiovascular diseases (CVDs). Second, the market is seeing innovation due to medical technology improvements like as implanted devices, innovative materials, and less invasive procedures. These developments are making it possible to create cardiovascular devices that are safer, more effective, and more patient-friendly. Global use of cardiovascular devices is also being fueled by rising healthcare spending, greater access to healthcare services, and government funding for preventive cardiology programmes. Additionally, the need for cardiovascular therapies is expanding due to factors such an ageing population, changing lifestyles, and the increased prevalence of obesity and diabetes. These factors are opening up new markets for the cardiovascular devices market.

According to Cognitive Market Research, the Cardiovascular Devices Market Size was USD XX Billion in 2024 and is set to achieve a market size of USD XX Billion by the end of 2033 growing at a CAGR of XX% from 2025 to 2033.

North America held largest share of XX% in the year 2024 
Europe held share of XX% in the year 2024 
Asia-Pacific held significant share of XX% in the year 2024 
South America held significant share of XX% in the year 2024
Middle East and Africa held significant share of XX% in the year 2024 

Market Dynamics of the Cardiovascular Devices Market

Key Drivers for the Cardiovascular Devices Market

Rising in cardiovascular diseases prevalence fuels the cardiovascular devices market

The cardiovascular disorders are the group of medical condition where it affects heart and blood vessels, encompassing various diseases and disorder that affects on the circulatory system. The cardiac devices help to maintain the regular heart function and blood flow in patients with weak improper function of heart. The global cardiac device market shows significant growth, largely driven by increase in prevalence of heart disease. The cardiovascular disease treatment is costly in terms of healthcare services. Now the conditions like coronary artery disease and heart failure are becoming increasingly prevalent, so there is increase in demand of coronary stents and crucial devices which are used to treat the cardiovascular diseases. Also, the global population increases and continues to age the incidence of chronic heart condition is expected to rise. This demographic condition is shift further and results in growing need of cardiovascular devices that can treat the wide range of heart diseases.

For instance, according to centers for disease control and prevention (CDC) in the United States heart diseases is the major cause of death for both men and women and people of most racial and ethnic groups. They said that one person dies every 33 seconds from cardiovascular disease. In 2022, 702,880 people died from heart disease. That is equivalent to 1 in every 5 deaths

(Source -https://www.cdc.gov/heart-disease/index.html)

Thus, due to the rising patients in cardiovascular disease segment and the advancement in technology boosts the cardiovascular devices market. Rising awareness of health also helps to drive this market.

The rise in healthcare expenditure drives the Cardiovascular Devices Market

Globally the health awareness is increasing vastly countries monitor their health of the population related to cardiac health preferably. They also focus on the expansion of healthcare expenditure where the people also now get aware about their health. The advancement in technology of medical devices increases the patient convenience and now they can get treatment and monitor their health more effectively. Each country now spends on their healthcare expenditure to provide healthcare service to all needy people who cannot afford the costly devices. For instance, U.S. health expenditure grew by 4.1% in 2022 to $4.5 trillion or $13,493 per capita. This rate of growth is similar to pre-pandemic levels (4.1% in 2019). While government expenditure to contain the pandemic resulted in significant growth in NHE, these expenditures fell sharply in 2021 while use of medical goods and services recovered. By 2022, overall trends in health expenditure more closely approximated that of the pre-pandemic era.

(Source - https://www.ama-assn.org/about/research/trends-health-care-spending)

The market for cardiovascular devices is expected to grow as a result of rising healthcare costs. The total amount spent on healthcare-related services, goods, and activities over a given time period usually at the individual, community, national, or international level is referred to as healthcare expenditures. Adoption of cutting-edge cardiovascular technologies and devices is made possible by increased healthcare spending, which improves patient outcomes and care. For Instance, in Europe the spending on cardiovascular disease is greater than the spending done in Germany. CVD is estimated to cost the EU €282 billion annually, with health and long-term care accounting for €155 billion (55%), equaling 11% of EU-health expenditure. Productivity losses accounted for 17% (€48 billion), whereas informal care costs were €79 billion (28%). CVD ...

Cardiovascular Device Market size to hit USD 128.23 billion by 2034, market analysis reveals breakthrough stents, pacemakers & AI-powered monitoring solutions

The Chilean cardiovascular devices market, valued at an estimated $100 million in 2025, is projected to experience steady growth, driven by factors such as increasing prevalence of cardiovascular diseases, a rising geriatric population, and improving healthcare infrastructure. The market's Compound Annual Growth Rate (CAGR) of 2.40% from 2025 to 2033 indicates a consistent, albeit moderate, expansion. This growth is fueled by rising adoption of minimally invasive procedures, technological advancements in device design leading to improved outcomes, and increased government initiatives focused on improving cardiovascular health. The market segmentation reveals strong demand for both diagnostic and monitoring devices (ECG, remote cardiac monitoring systems) and therapeutic and surgical devices (cardiac rhythm management devices, stents, heart valves). Major players like Boston Scientific, Medtronic, and Siemens Healthineers are actively engaged in the Chilean market, contributing to its development through product innovation and distribution networks. However, factors such as high device costs, limited healthcare access in certain regions, and the presence of generic alternatives could pose challenges to sustained market expansion. The market's performance is expected to be influenced by several factors. Government healthcare policies, including investment in public health programs and reimbursement schemes for advanced cardiovascular devices, will play a crucial role. The adoption of telehealth technologies for remote patient monitoring is anticipated to boost the market segment for remote cardiac monitoring devices. Furthermore, the expanding private healthcare sector and increasing medical tourism could contribute positively to market growth. A potential constraint could be the economic conditions in Chile and its impact on healthcare spending. Nonetheless, the overall outlook remains positive, suggesting a stable and gradually expanding cardiovascular devices market in Chile throughout the forecast period (2025-2033). Key drivers for this market are: , Increasing Burden of Cardiovascular Diseases; Increased Preference of Minimally Invasive Procedures. Potential restraints include: , Increasing Burden of Cardiovascular Diseases; Increased Preference of Minimally Invasive Procedures. Notable trends are: Electrocardiogram (ECG) is Expected to Dominate the Diagnostic And Monitoring Segment Over the Forecast Period.

Global Cardiovascular Devices market size is expected to reach $93.49 billion by 2029 at 6.7%, rising prevalence of cardiovascular disorders fuels growth in the cardiovascular device market

Cardiovascular Devices Market is estimated to be USD 132.3 Billion by 2034 with a CAGR of 7.90% during the forecast period.

Global Cardiovascular Devices market size was $7.98 billion in 2023 and is slated to hit $14.36 billion by the end of 2032 with a CAGR of 6.74%.

Snapshot img

Cardiovascular Medical Devices Market Size 2025-2029

The cardiovascular medical devices market size is forecast to increase by USD 21.71 billion at a CAGR of 7.6% between 2024 and 2029.

The market is driven by the escalating incidence of cardiovascular diseases and the expansion of insurance providers' coverage for related treatments. Market players are responding with innovative business strategies, including product development and strategic collaborations, to capitalize on these opportunities. However, the high cost of cardiovascular procedures poses a significant challenge for both patients and providers, potentially limiting market growth. Artificial intelligence and wireless technologies, such as Al-based electrocardiograms, implantable loop recorders, and event monitors, are also gaining popularity for their ability to improve diagnostic accuracy and patient care.
Effective cost management and continuous innovation will be essential for market success. As the population ages and cardiovascular diseases become increasingly prevalent, companies must navigate this financial obstacle while maintaining quality and affordability to meet patient needs and remain competitive. Companies in this market are focusing on innovative technologies like Al and machine learning based electrocardiogram (ECG) technology to improve the accuracy and efficiency of cardiovascular diagnosis.

What will be the Size of the Cardiovascular Medical Devices Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report.
Request Free Sample

The Cardiovascular Devices Market encompasses diagnostic monitoring devices, surgical devices, and cardiology devices used to prevent and manage heart disorders, including cardiomyopathy, heart failure, stroke, and heart-related mortality. According to the World Health Organization, cardiovascular diseases are the leading cause of death worldwide, making this market crucial for addressing healthcare resources and improving patient outcomes. Emerging nations are increasingly investing in advanced cardiovascular devices, such as AI-based ECG technology and minimally invasive procedures, to reduce fatal conditions like heart failure and stroke. The market is witnessing significant trends, including the integration of artificial intelligence in diagnostics and the development of more sophisticated surgical devices, such as coronary artery stents.

Cardiovascular Diseases, including heart disorders and heart-related mortality, are major health concerns, and the demand for diagnostic monitoring devices, such as Holter monitors, is on the rise. The market's growth is driven by the need for early detection and effective management of cardiovascular conditions, as well as advancements in technology, such as minimally invasive procedures and AI-based electrocardiogram technology. The Cardiovascular Devices Market is expected to continue growing, as healthcare systems in both developed and emerging nations seek to improve patient care and reduce the burden of cardiovascular diseases. With advancements in technology and a growing focus on preventative care, the market is poised for continued growth and innovation.

How is this Cardiovascular Medical Devices Industry segmented?

The cardiovascular medical devices industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Product

  Diagnostic systems
  Surgical devices


Disease Type

  Coronary artery disease
  Arrhythmia
  Heart failure
  Structural heart disease
  Others


End-user

  Hospitals
  ASCs
  Specialty clinics
  Home healthcare settings
  Rehabilitation centers


Geography

  North America

    US
    Canada
    Mexico


  Europe

    France
    Germany
    Italy
    UK


  APAC

    China
    India
    Japan


  Rest of World (ROW)

By Product Insights

The Diagnostic systems segment is estimated to witness significant growth during the forecast period. The market encompasses a vast array of technologies and devices designed to diagnose, monitor, and treat heart disorders and diseases. This market includes innovative solutions such as AI-based electrocardiogram (ECG) technology, implantable loop recorders, cardiac CT scans, and minimally invasive procedures for detecting clogged arteries and assessing heart function. Valves, pacemakers, stents, Holter monitors, and electrosurgical procedures are among the essential cardiovascular devices used for treating various heart conditions. The World Health Organization reports that cardiovascular diseases (CVDs) are the leading cause of heart-related mortality worldwide. Fatal conditions like atrial fibrillation, stroke, and heart attacks n

Cardiovascular Devices Market size is growing with a CAGR of 7.8% in the prediction period & it crosses USD 1,12,366.1 Mn by 2032 from USD 66,420.8 Mn in 2025

The China Cardiovascular Devices Market Report is Segmented by Device Type (Diagnostic & Monitoring Devices, Therapeutic & Surgical Devices), Application (Coronary Artery Disease, Arrhythmia & Conduction Disorders, Heart Failure & Cardiomyopathy, and More), End-User (Hospitals & Cardiac Centres, Ambulatory Surgical Centres, and More). The Market Forecasts are Provided in Terms of Value (USD).

Find detailed analysis in Market Research Intellect's Cardiovascular Devices Market Report, estimated at USD 50.3 billion in 2024 and forecasted to climb to USD 75.2 billion by 2033, reflecting a CAGR of 5.5%.Stay informed about adoption trends, evolving technologies, and key market participants.

The U.S. cardiovascular devices market was valued at USD 22.35 billion in 2024 and is expected to grow to USD 38.49 billion by 2034, registering a CAGR of 5.6% during the forecast period from 2025 to 2034.

This statistic shows the value of the cardiovascular devices market in the U.S. in 2007 and 2014, with a forecast for 2021, by category. In 2014, the total value of the cardiovascular devices market in the U.S. was around 15.7 billion dollars, with cardiac rhythm management devices accounting for the largest share of this total with almost 5.7 billion dollars.

The UK Cardiovascular Devices Market Report is Segmented by Product Type (Diagnostic & Monitoring Devices, Therapeutic & Surgical Devices), Application (Coronary Artery Disease, Arrhythmia & Conduction Disorders, Heart Failure & Cardiomyopathy, Structural & Congenital Heart Defects, and More), End User (Hospitals & Cardiac Centres, Ambulatory Surgical Centres, and More). The Market Forecasts are Provided in Terms of Value (USD).

[231+ Pages Report] The global cardiovascular devices market size is expected to grow from USD 5.8 billion in 2022 to USD 20.34 billion by 2030, at a CAGR of 13% from 2023-2030

Cardiovascular Devices Market Outlook

According to our latest research, the global cardiovascular devices market size reached USD 65.7 billion in 2024, driven by a robust demand for advanced diagnostic and therapeutic solutions across the globe. The market is projected to grow at a CAGR of 6.2% from 2025 to 2033, reaching an estimated value of USD 112.5 billion by the end of the forecast period. This growth is primarily fueled by the increasing prevalence of cardiovascular diseases, technological innovations, and expanding healthcare infrastructure worldwide. As per our comprehensive analysis, the market is set to witness significant expansion, particularly in emerging economies and among aging populations, which are contributing to higher adoption rates of cardiovascular devices.

One of the most significant growth factors propelling the cardiovascular devices market is the rising global burden of cardiovascular diseases (CVDs). With lifestyle changes, urbanization, and the growing incidence of risk factors such as obesity, diabetes, hypertension, and sedentary habits, the prevalence of CVDs has seen a marked increase. According to the World Health Organization, cardiovascular diseases remain the leading cause of mortality globally, accounting for nearly 17.9 million deaths each year. This alarming statistic underscores the urgent need for effective diagnostic and therapeutic interventions, thereby driving the demand for advanced cardiovascular devices. Furthermore, the growing awareness about early diagnosis and preventive healthcare is encouraging patients and healthcare providers to invest in state-of-the-art monitoring and surgical equipment, ensuring sustained market growth.

Technological advancements have been another critical driver of the cardiovascular devices market. The integration of cutting-edge technologies such as artificial intelligence, robotics, and minimally invasive surgical techniques has revolutionized the diagnosis and treatment of cardiovascular conditions. Innovations in imaging modalities, wearable cardiac monitors, and implantable devices have significantly improved patient outcomes and reduced recovery times. Additionally, the development of next-generation drug-eluting stents, bioresorbable scaffolds, and advanced pacemakers has broadened the therapeutic landscape, offering tailored solutions for complex cardiac cases. The continuous research and development activities undertaken by leading medical device manufacturers are expected to further accelerate market expansion, as healthcare systems worldwide strive to adopt the latest advancements to enhance patient care.

The increasing healthcare expenditure and supportive government initiatives are also contributing to the growth of the cardiovascular devices market. Many countries are investing heavily in upgrading their healthcare infrastructure, particularly in emerging regions such as Asia Pacific and Latin America. These investments are aimed at improving access to quality cardiac care, expanding the availability of advanced diagnostic and surgical equipment, and fostering public-private partnerships. Moreover, favorable reimbursement policies and regulatory approvals for innovative devices are encouraging market players to introduce new products and expand their geographical footprint. The collective impact of these factors is expected to sustain the upward trajectory of the global cardiovascular devices market over the forecast period.

From a regional perspective, North America currently dominates the cardiovascular devices market, accounting for the largest share due to its well-established healthcare infrastructure, high prevalence of cardiovascular diseases, and strong presence of leading market players. However, the Asia Pacific region is anticipated to witness the highest growth rate during the forecast period, driven by increasing healthcare investments, rising awareness, and a rapidly aging population. Europe also holds a significant share, supported by advanced medical technologies and favorable government policies. Meanwhile, Latin America and the Middle East & Africa are gradually emerging as lucrative markets, owing to improving healthcare access and growing demand for cardiovascular interventions. This regional diversification is expected to create new opportunities for market players and drive overall industry growth.